296 related articles for article (PubMed ID: 16649976)
21. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
Kedzia A; Obara-Moszyńska M; Korman E; Rabska-Pietrzak B; Kopinski P; Trojan J; Goździcka-Józefiak A
Rocz Akad Med Bialymst; 2003; 48():28-33. PubMed ID: 14737937
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
23. Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study.
Di Battista E; Naselli A; Queirolo S; Gallarotti F; Garré ML; Milanaccio C; Cama A
J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():431-7. PubMed ID: 16700321
[TBL] [Abstract][Full Text] [Related]
24. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
25. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
Li GM; Sun XJ; Shao P
Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279
[TBL] [Abstract][Full Text] [Related]
26. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset.
Columb B; Smethurst LE; Mukherjee A; Jostel A; Shalet SM; Murray RD
Clin Endocrinol (Oxf); 2009 Feb; 70(2):281-6. PubMed ID: 18702681
[TBL] [Abstract][Full Text] [Related]
27. Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma.
Pemberton LS; Dougal M; Magee B; Gattamaneni HR
Radiother Oncol; 2005 Oct; 77(1):99-104. PubMed ID: 16216361
[TBL] [Abstract][Full Text] [Related]
28. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
[TBL] [Abstract][Full Text] [Related]
29. Hurthle cell neoplasm of the thyroid gland.
Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
[TBL] [Abstract][Full Text] [Related]
30. Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study.
Smith TR; Cote DJ; Jane JA; Laws ER
J Neurosurg Pediatr; 2016 Oct; 18(4):408-412. PubMed ID: 27286443
[TBL] [Abstract][Full Text] [Related]
31. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
[TBL] [Abstract][Full Text] [Related]
32. Assessment of hydration by means of bioelectrical impedance and arm muscle area during growth hormone (GH) replacement therapy: A prospective study of 130 GH-deficient patients.
Badre-Esfahani S; Nellemann B; Danielsen D; Fisker S; Christiansen JS; Jørgensen JO
Growth Horm IGF Res; 2007 Jun; 17(3):227-33. PubMed ID: 17347010
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
34. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
[TBL] [Abstract][Full Text] [Related]
35. Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).
Binder G; Iliev DI; Mullis PE; Ranke MB
Growth Horm IGF Res; 2007 Jun; 17(3):242-8. PubMed ID: 17360215
[TBL] [Abstract][Full Text] [Related]
36. Perioperative dexamethasone treatment in childhood craniopharyngioma--influence on short-term and long-term weight gain.
Müller HL; Heinrich M; Bueb K; Etavard-Gorris N; Gebhardt U; Kolb R; Sörensen N
Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):330-4. PubMed ID: 14520598
[TBL] [Abstract][Full Text] [Related]
37. [Craniopharyngiomas. Neurosurgical treatment and therapeutic results].
Lauenborg J; Kosteljanetz M
Ugeskr Laeger; 1995 Aug; 157(34):4673-6. PubMed ID: 7645112
[TBL] [Abstract][Full Text] [Related]
38. [Two cases of recurrent brain tumor during GH replacement therapy].
Watanabe H; Iwasa S; Uki J; Takeda F; Isobe I
No Shinkei Geka; 1992 Sep; 20(9):1009-12. PubMed ID: 1407352
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation.
Haddy TB; Mosher RB; Nunez SB; Reaman GH
Pediatr Blood Cancer; 2006 Feb; 46(2):258-61. PubMed ID: 16369923
[TBL] [Abstract][Full Text] [Related]
40. Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital.
Fitzek MM; Linggood RM; Adams J; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1348-54. PubMed ID: 16580494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
